Investors sentiment increased to 1.19 in Q4 2018. Its up 0.04, from 1.15 in 2018Q3. It increased, as 34 investors sold PetMed Express, Inc. shares while 40 reduced holdings. 38 funds opened positions while 50 raised stakes. 20.00 million shares or 10.50% more from 18.10 million shares in 2018Q3 were reported.
Ls Investment Ltd reported 619 shares stake. Arizona State Retirement System reported 0.01% stake. Gradient Invs Limited Company holds 0% or 398 shares. Gotham Asset Mngmt Limited Liability Corp has invested 0.03% in PetMed Express, Inc. (NASDAQ:PETS). Newtyn Mngmt Ltd Company has invested 0.68% in PetMed Express, Inc. (NASDAQ:PETS). Smith Asset Management Group Incorporated Ltd Partnership invested in 18,839 shares. State Of Alaska Department Of Revenue holds 0% of its portfolio in PetMed Express, Inc. (NASDAQ:PETS) for 6,908 shares. New Amsterdam Prtn Lc Ny holds 0.77% in PetMed Express, Inc. (NASDAQ:PETS) or 99,982 shares. Manchester Cap Mgmt Limited Co reported 678 shares or 0% of all its holdings. Royal State Bank Of Canada holds 0% in PetMed Express, Inc. (NASDAQ:PETS) or 2,963 shares. Aperio Gp Ltd Co, a California-based fund reported 16,219 shares. Polaris Mngmt Ltd Co invested in 0.11% or 103,900 shares. State Teachers Retirement holds 0% in PetMed Express, Inc. (NASDAQ:PETS) or 64,138 shares. North Star Inv Mgmt Corporation, a Illinois-based fund reported 114,456 shares. Profit Inv Mngmt Ltd Limited Liability Company invested in 102,725 shares or 2.17% of the stock.
The stock of PetMed Express, Inc. (NASDAQ:PETS) is a huge mover today! The stock increased 1.02% or $0.21 during the last trading session, reaching $20.71. About 625,934 shares traded. PetMed Express, Inc. (NASDAQ:PETS) has declined 50.36% since March 23, 2018 and is downtrending. It has underperformed by 54.73% the S&P500.
The move comes after 8 months positive chart setup for the $424.20 million company. It was reported on Mar, 23 by Barchart.com. We have $22.16 PT which if reached, will make NASDAQ:PETS worth $29.69 million more.
More notable recent PetMed Express, Inc. (NASDAQ:PETS) news were published by: Nasdaq.com which released: “PetIQ, Inc. Announces Appointment of R. Michael Herrman as General Counsel – Nasdaq” on February 25, 2019, also Nasdaq.com with their article: “Tractor Supply’s Spring Paper Clover Program to Provide Thousands of Leadership Opportunities for 4-H Youth – Nasdaq” published on March 20, 2019, Seekingalpha.com published: “PetMed Express: A Dog House Value Trap – Seeking Alpha” on February 06, 2019. More interesting news about PetMed Express, Inc. (NASDAQ:PETS) were released by: Nasdaq.com and their article: “Mid-Day ETF Update: ETFs, Stocks Continue to Trade Lower as Widening Trade Deficit, Lower OECD Global Growth Forecast Weigh – Nasdaq” published on March 06, 2019 as well as Globenewswire.com‘s news article titled: “CBD Is Going to The Dogs: Continued Growth in Hemp Derived Pet Products – GlobeNewswire” with publication date: March 04, 2019.
PetMed Express, Inc. and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company has market cap of $424.20 million. The firm markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats to retail customers. It has a 10.3 P/E ratio. It provides non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, thyroid, diabetes, pain medications, antibiotics, and other specialty medications, as well as generic substitutes.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.